Key Highlights
- Strata Critical Medical shares closed up 4.72% at $4.55 on Oct. 16, 2026.
- Third Point holds a 5.8% stake in the company.
- Third Point moved from a 13G passive filing to a 13D activist filing.
- Second-quarter revenue rose 61% to $72.5 million.
- Market capitalization stands at roughly $402.08 million.
Third Point Turns Activist and Presses for a Possible Sale
Strata Critical Medical (NASDAQ:SRTA) closed up 4.72% at $4.55 on Oct. 16, 2026, after investor Third Point called on the company to weigh strategic alternatives, including a potential sale. Third Point, which owns a 5.8% stake, changed its regulatory filing from a 13G, used by passive holders, to a 13D, used by activist investors. Volume reached about 1.33 million shares.
Third Point first disclosed buying shares in August 2025, when the company still operated as Blade Air Mobility. The switch to activist status signals a more direct push on the board.
Overhead Costs and Management Incentive Options Draw Scrutiny
Third Point said it views the underlying business as strong but too small to support its current overhead. It also argued that management incentive options are not aligned with creating value for shareholders.
Strata, headquartered in New York, provides time-critical logistics and medical services for the U.S. organ transplant sector. Its Logistics segment handles air and ground organ transport and placement, mainly under the Trinity Medical Solutions brand. The Clinical segment covers organ recovery, normothermic regional perfusion, cardiac perfusion and ECMO. The company has 327 employees and is led by chief executive Melissa Tomkiel.
Revenue Jump Follows the Pivot to Medical Logistics
The company rebranded in August 2025 after selling its passenger business to Joby Aviation (NYSE:JOBY). Management said the move created a pure-play, contract-based medical business serving fast-growing markets that do not track the broader economy. The company originally debuted on Nasdaq in May 2021 through a blank-check transaction.
In August, Strata reported second-quarter revenue growth of 61% to $72.5 million. The stock carries a market capitalization of about $402.08 million, a forward price-to-earnings ratio of 75.75 and earnings per share of negative $0.21. Shares sit within a 52-week range of $3.95 to $6.50.
Outlook: Board Response to Activist Pressure Is the Next Marker
Third Point's shift to a 13D filing brings the cost structure, management incentives and a possible sale into open discussion. The next thing to watch is whether the board responds publicly or opens a formal review of alternatives. Further regulatory filings from Third Point could add detail on its demands.






Please wait processing your request...